Primary |
Growth Hormone Deficiency |
23.8% |
Drug Use For Unknown Indication |
16.4% |
Haemodialysis |
10.7% |
Product Used For Unknown Indication |
9.4% |
Hypertension |
5.6% |
Body Height Below Normal |
5.4% |
Asthma |
3.3% |
Ill-defined Disorder |
3.1% |
Hypopituitarism |
2.9% |
Prophylaxis |
2.8% |
Hypothyroidism |
2.6% |
Rheumatoid Arthritis |
1.9% |
Diabetes Insipidus |
1.8% |
Type 2 Diabetes Mellitus |
1.7% |
Growth Retardation |
1.5% |
Hypersensitivity |
1.5% |
Blood Cholesterol Increased |
1.4% |
Cough |
1.4% |
Cushing's Syndrome |
1.4% |
Insulin Resistance |
1.4% |
|
Craniopharyngioma |
7.0% |
Death |
7.0% |
Vomiting |
7.0% |
Tonsillar Hypertrophy |
6.2% |
Urinary Tract Infection |
6.2% |
Hyperglycaemia |
5.4% |
Azotaemia |
4.7% |
Gastrointestinal Haemorrhage |
4.7% |
Haemoptysis |
4.7% |
Malignant Melanoma |
4.7% |
Myocardial Infarction |
4.7% |
Papilloedema |
4.7% |
Retinal Detachment |
4.7% |
Sleep Apnoea Syndrome |
4.7% |
Type 1 Diabetes Mellitus |
4.7% |
Blood Glucose Increased |
3.9% |
Chest Pain |
3.9% |
Convulsion |
3.9% |
Haemorrhage Intracranial |
3.9% |
Osteonecrosis |
3.9% |
|
Secondary |
Growth Hormone Deficiency |
17.5% |
Product Used For Unknown Indication |
12.8% |
Haemodialysis |
9.5% |
Chondrodystrophy |
6.2% |
Body Height Below Normal |
5.9% |
Hypertension |
5.9% |
Hypopituitarism |
5.9% |
Hypothyroidism |
4.7% |
Convulsion |
3.9% |
Drug Use For Unknown Indication |
3.9% |
Cardiac Failure |
3.0% |
Diabetes Mellitus |
2.7% |
Fatigue |
2.7% |
Prophylaxis |
2.7% |
Renal Failure Chronic |
2.7% |
Diarrhoea |
2.4% |
Diabetes Insipidus |
2.1% |
Hypersensitivity |
2.1% |
Hyperphosphataemia |
1.8% |
Weight Increased |
1.8% |
|
Condition Aggravated |
11.5% |
Sleep Apnoea Syndrome |
8.7% |
Death |
6.7% |
Syncope |
6.7% |
Craniopharyngioma |
5.8% |
Transient Ischaemic Attack |
5.8% |
Urinary Tract Infection |
5.8% |
Weight Decreased |
5.8% |
Hyperglycaemia |
4.8% |
Blood Glucose Increased |
3.8% |
Convulsion |
3.8% |
Empty Sella Syndrome |
3.8% |
Myocardial Infarction |
3.8% |
Papilloedema |
3.8% |
Pneumonia |
3.8% |
Transaminases Increased |
3.8% |
Diarrhoea |
2.9% |
Stevens-johnson Syndrome |
2.9% |
Type 1 Diabetes Mellitus |
2.9% |
Vomiting |
2.9% |
|
Concomitant |
Hypopituitarism |
36.4% |
Prophylaxis |
36.4% |
Osteogenesis Imperfecta |
18.2% |
Pyrexia |
9.1% |
|
|